1. Home
  2. NCNO vs BHVN Comparison

NCNO vs BHVN Comparison

Compare NCNO & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo nCino Inc.

NCNO

nCino Inc.

N/A

Current Price

$19.67

Market Cap

2.1B

Sector

Technology

ML Signal

N/A

Logo Biohaven Ltd.

BHVN

Biohaven Ltd.

N/A

Current Price

$12.14

Market Cap

2.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NCNO
BHVN
Founded
2011
2013
Country
United States
United States
Employees
1684
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
2.1B
IPO Year
2022
2022

Fundamental Metrics

Financial Performance
Metric
NCNO
BHVN
Price
$19.67
$12.14
Analyst Decision
Buy
Buy
Analyst Count
14
17
Target Price
★ $24.27
$21.27
AVG Volume (30 Days)
2.1M
★ 2.7M
Earning Date
08-25-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 115.15
26.08
EPS
★ 0.18
N/A
Revenue
★ $594,781,000.00
N/A
Revenue This Year
$8.63
N/A
Revenue Next Year
$8.52
N/A
P/E Ratio
$109.33
★ N/A
Revenue Growth
★ 10.01
N/A
52 Week Low
$13.80
$7.48
52 Week High
$27.50
$18.57

Technical Indicators

Market Signals
Indicator
NCNO
BHVN
Relative Strength Index (RSI) 48.28 39.83
Support Level $19.14 $11.93
Resistance Level $19.71 $13.08
Average True Range (ATR) 0.81 0.71
MACD 0.02 -0.11
Stochastic Oscillator 62.40 19.37

Price Performance

Historical Comparison
NCNO
BHVN

About NCNO nCino Inc.

Ncino Inc is a provider of cloud-based software for financial institutions. It is focused on developing the nCino Platform to transform commercial and small business lending for community and regional banks in the U.S. With the company's platform financial institutions can Operate More Intelligently, Improve Efficiency, Elevate Employee and Client Experiences, and Manage Risk and Compliance Continuously Rather Than Reactively. It has built and acquired technology, including SimpleNexus, DocFox, FullCircl, ILT, Visible Equity, FinSuite, and Sandbox Banking, to augment the nCino Platform's capabilities for mortgage lending, onboarding, account opening, indirect auto lending, and analytics and AI. The company operates as one operating segment.

About BHVN Biohaven Ltd.

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder and others. Its pipeline products include: BHV-2000, BHV-7000, BHV-2100, BHV-8000, BHV-1310, BHV-1300, BHV-1400, BHV-1600, BHV-1530, and BHV-1500.

Share on Social Networks: